Skip to main content

Site notifications

International scientific guideline: Points to consider on the clinical requirements of modified release products submitted as a line extension of an existing marketing authorisation

CPMP/EWP/1875/03/Final adopted by the Therapeutic Goods Administration (TGA)

Help us improve the Therapeutic Goods Administration site